Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterCorrespondence

Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis

ARTHUR KAVANAUGH, TERESA CATALAN and SARAH CASSELL
The Journal of Rheumatology March 2012, 39 (3) 653; DOI: https://doi.org/10.3899/jrheum.110839
ARTHUR KAVANAUGH
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: akavanaugh@ucsd.edu
TERESA CATALAN
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SARAH CASSELL
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

To the Editor:

We read with great interest the report by Cauli, et al on patient assessments of disease activity in psoriatic arthritis (PsA)1. As part of an exercise validating an instrument to assess the activity of nail psoriasis2, the modified Nail Psoriasis Severity Index (mNAPSI), we collected detailed clinical information from a cohort of 20 patients with PsA. In addition to standard measures of peripheral arthritis, functional status, quality of life, and skin psoriasis activity, this included visual analog scales (VAS) with which patients separately assessed the global activity of their PsA, as well as the activity of skin involvement, joint involvement, and nail involvement. Pairwise correlations between various outcome measures were performed using Spearman’s rho. The patients had a mean age of 52.6 years, mean duration of psoriasis 18.8 years and PsA 11.0 years, mean tender joint count of 7.4/68 and swollen joint count 3.0/66, and a mean Psoriasis Area and Severity Index (PASI) score of 5.0. Correlations among selected measures are shown in Table 1.

View this table:
  • View inline
  • View popup
Table 1.

Correlations among selected measures. No adjustment has been made for multiple comparisons.

As might be expected, there was good correlation between joint counts and the physicians’ assessment of overall PsA disease activity, as well as between physician and patient global assessments. Function assessed by Health Assessment Questionnaire (HAQ) correlated with the joint counts and with the patient arthritis-specific VAS, as well as with the physical component summary (PCS) score of the Medical Outcomes Study Short Form-36 (SF-36). The SF-36 PCS also correlated with the patient arthritis-specific VAS. As has been reported, measures of joint activity and skin activity did not correlate very strongly3,4. Also, there was less strong correlation between skin activity and the PCS of the SF-36. Interestingly, different measures of skin activity (e.g., the PASI as compared to patient and physician VAS) did not correlate as strongly as might have been expected. Finally, whereas different measures of activity of nail disease (by mNAPSI and by patient global nail assessment) correlated well with each other, they did not correlate with measures of overall skin activity (PASI, patient global skin assessment). Nail involvement correlated with the PCS of the SF-36 comparable to skin involvement.

Our data support the findings by Cauli and colleagues. Accurate assessment of the various domains of PsA should include separate accounting for global severity of skin, joints, and also nails. Nail disease is increasingly recognized as of importance to patients with psoriasis; the choice of therapeutic regimen for patients with PsA or psoriasis should consider data specific to nail involvement3,4. A study by Williamson and colleagues assessed 69 patients with PsA and found correlations between nail disease severity and skin disease, enthesitis, polyarticular disease, HAQ score, higher depression and anxiety scores, and unremitting and progressive arthritis4. Scarpa and colleagues found a relationship between distal interphalangeal (DIP) arthritis in patients with PsA and the duration of nail psoriasis, although there was not a statistically significant correlation between the distribution of DIP arthritis and onychopathy5.

In our cohort, DIP joint arthritis was not associated with nail involvement, but active DIP arthritis was not common. In addition, we found no strong correlation between mNAPSI and overall measures of arthritis, including patient global VAS for arthritis activity, tender joint count, and swollen joint count.

We therefore agree with Cauli and colleagues that assessment of the various domains of PsA should include separate VAS measures for the global severity of skin, joints, and also nail involvement.

REFERENCES

  1. 1.↵
    1. Cauli A,
    2. Gladman DD,
    3. Mathieu A,
    4. Olivieri I,
    5. Porru G,
    6. Tak PP,
    7. et al.
    Patient global assessment in psoriatic arthritis: A multicenter GRAPPA and OMERACT study. J Rheumatol 2011;38:898–903.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Cassell S,
    2. Bieber J,
    3. Rich P,
    4. Tutuncu Z,
    5. Lee SJ,
    6. Kalunian K,
    7. et al.
    The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007;34:123–9.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Cassell SE,
    2. Kavanaugh A
    . Therapies for psoriatic nail disease. A systematic review. J Rheumatol 2006;33:1452–6.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Williamson L,
    2. Dalbeth N,
    3. Dockerty JL,
    4. Gee BC,
    5. Weatherall R,
    6. Wordsworth BP
    . Extended report: Nail disease in psoriatic arthritis — clinically important, potentially treatable and often overlooked. Rheumatology 2004;43:790–4.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Scarpa R,
    2. Manguso F,
    3. Oriente A,
    4. Peluso R,
    5. Attno M,
    6. Oriente P
    . Is the involvement of distal interphalangeal joint in psoriatic patients related to nail psoriasis? Clin Rheumatol 2004;23:27–30.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 39, Issue 3
1 Mar 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis
ARTHUR KAVANAUGH, TERESA CATALAN, SARAH CASSELL
The Journal of Rheumatology Mar 2012, 39 (3) 653; DOI: 10.3899/jrheum.110839

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis
ARTHUR KAVANAUGH, TERESA CATALAN, SARAH CASSELL
The Journal of Rheumatology Mar 2012, 39 (3) 653; DOI: 10.3899/jrheum.110839
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Dr. Yoshida et al reply
  • A Rare Case of Parvovirus B19-Induced Atlantoaxial Arthritis
  • Dr. Solomon et al reply
Show more Correspondence

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire